Analytical sensitivity and stability of DNA methylation testing in stool samples for colorectal cancer detection

Cellular Oncology

Volumn 35, Issue 4, 2012, Pages 309-315

  Bosch, Linda J W ^a   Mongera, Sandra ^a   Droste, Jochim S Terhaar Sive ^a   Oort, Frank A ^a   Van Turenhout, Sietze T ^a   Penning, Maarten T ^b   Louwagie, Joost ^b   Mulder, Chris J J ^a   Van Engeland, Manon ^c   Carvalho, Beatriz ^a   Meijer, Gerrit A ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b OncoMethylome Sciences SA   (Belgium)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Analytical sensitivity; CRC; DNA methylation; FIT; IFOBT; Screening; Stability; Stool

Indexed keywords

BETA ACTIN; HEMOGLOBIN BETA CHAIN; K RAS PROTEIN; PHOSPHATASE AND ACTIN REGULATOR 3; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; COPY NUMBER VARIATION; DNA DEGRADATION; DNA ISOLATION; DNA METHYLATION; FECES ANALYSIS; GENE MUTATION; HUMAN; HUMAN CELL; MOLECULAR STABILITY; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

BASE SEQUENCE; BETA-GLOBINS; CELL CYCLE PROTEINS; COLORECTAL NEOPLASMS; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; FEASIBILITY STUDIES; FECES; GENETIC TESTING; HCT116 CELLS; HUMANS; MUTATION; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TEMPERATURE; TIME FACTORS;

EID: 84870018290     PISSN: 22113428     EISSN: 22113436     Source Type: Journal    
DOI: 10.1007/s13402-012-0092-6     Document Type: Article

References (27)

1. J.E. Allison, M. Lawson, Screening tests for colorectal cancer: a menu of options remains relevant. Curr. Oncol. Rep. 8, 492-498 (2006) (Pubitemid 44697779)
2. G. Hoff, J.A. Dominitz, Contrasting US and European approaches to colorectal cancer screening: which is best? Gut 59, 407-414 (2010)
3. D.R. Wang, D. Tang, Hypermethylated SFRP2 gene in fecal DNA is a high potential biomarker for colorectal cancer noninvasive screening. World J. Gastroenterol. 14, 524-531 (2008) (Pubitemid 351320817)
4. S.C. Glockner, M. Dhir, J.M. Yi, K.E. McGarvey, N.L. Van, J. Louwagie, T.A. Chan, W. Kleeberger, A.P. de Bruine, K.M. Smits, C.A. Khalid-de Bakker, D.M. Jonkers, R.W. Stockbrugger, G.A. Meijer, F.A. Oort, C. Iacobuzio-Donahue, K. Bierau, J.G. Herman, S.B. Baylin, E.M. Van, K.E. Schuebel, N. Ahuja, Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer. Cancer Res. 69, 4691-4699 (2009)
5. V. Melotte, M.H. Lentjes, S.M. van den Bosch, D.M. Hellebrekers, J.P. de Hoon, K.A. Wouters, K.L. Daenen, I.E. Partouns-Hendriks, F. Stessels, J. Louwagie, K.M. Smits, M.P.Weijenberg, S. Sanduleanu, C.A. Khalid-de Bakker, F.A. Oort, G.A. Meijer, D.M. Jonkers, J.G. Herman, A.P. de Bruine, E.M. Van, N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer. J Natl Cancer Inst 101, 916-927 (2009)
6. L.J. Bosch, F.A. Oort, M. Neerincx, C.A. Khalid-de Bakker, J.S. Terhaar Sive Droste, V. Melotte, D.M. Jonkers, A.A. Masclee, S. Mongera, M. Grooteclaes, J. Louwagie, C.W. Van, V.M. Coupe, C.J. Mulder, E.M. Van, B. Carvalho, G.A. Meijer, DNA methylation of phosphatase and actin regulator 3 detects colorectal cancer in stool and complements FIT. Cancer Prev Res Phila 5, 464-472 (2012)
7. Y.X. Luo, D.K. Chen, S.X. Song, L. Wang, J.P. Wang, Aberrant methylation of genes in stool samples as diagnostic biomarkers for colorectal cancer or adenomas: a meta-analysis. Int. J. Clin. Pract. 65, 1313-1320 (2011)
8. L.J. Bosch, B. Carvalho, R.J. Fijneman, C.R. Jimenez, H.M. Pinedo, E.M. Van, G.A. Meijer, Molecular tests for colorectal cancer screening. Clin. Colorectal Cancer 10, 8-23 (2011)
9. J. Olson, D.H. Whitney, K. Durkee, A.P. Shuber, DNA stabilization is critical formaximizing performance of fecal DNA-based colorectal cancer tests. Diagn. Mol. Pathol. 14, 183-191 (2005) (Pubitemid 41391802)
10. F.A. Oort, J.S. Droste, R.W. Van Der Hulst, H.A. Van Heukelem, R.J. Loffeld, I.C. Wesdorp, R.L. Van Wanrooij, B.L. De, E.R. Mutsaers, R.S. Van Der, V.M. Coupe, J. Berkhof, A.A. Bouman, G.A. Meijer, C.J. Mulder, Colonoscopy-controlled intra-individual comparisons to screen relevant neoplasia: faecal immunochemical test vs. guaiac-based faecal occult blood test. Aliment. Pharmacol. Ther. 31, 432-439 (2010)
11. T.E. Buffart, M. Tijssen, T. Krugers, B. Carvalho, S.J. Smeets, R.H. Brakenhoff, H. Grabsch, G.A. Meijer, H.B. Sadowski, B. Ylstra, DNA quality assessment for array CGH by isothermal whole genome amplification. Cell. Oncol. 29, 351-359 (2007) (Pubitemid 47037249)
12. M.L. Janmaat, J.A. Rodriguez, M. Gallegos-Ruiz, F.A. Kruyt, G. Giaccone, Enhanced cytotoxicity induced by gefitinib and specific inhibitors of the Ras or phosphatidyl inositol-3 kinase pathways in non-small cell lung cancer cells. Int. J. Cancer 118, 209-214 (2006) (Pubitemid 41681601)
13. M.I. Gallegos Ruiz, K. Floor, F. Rijmen, K. Grunberg, J.A. Rodriguez, G. Giaccone, EGFR and K-rasmutation analysis in non-small cell lung cancer: comparison of paraffin embedded versus frozen specimens. Cell. Oncol. 29, 257-264 (2007) (Pubitemid 46855706)
14. J.C. Brandes, E.M. Van, K.A. Wouters, M.P. Weijenberg, J.G. Herman, CHFR promoter hypermethylation in colon cancer correlates with the microsatellite instability phenotype. Carcinogenesis 26, 1152-1156 (2005) (Pubitemid 41214309)
15. Z. Levi, P. Rozen, R. Hazazi, A. Vilkin, A. Waked, E. Maoz, S. Birkenfeld, M. Leshno, Y. Niv, A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann. Intern. Med. 146, 244-255 (2007) (Pubitemid 351650610)
16. D.A. Ahlquist, D.J. Sargent, C.L. Loprinzi, T.R. Levin, D.K. Rex, D.J. Ahnen, K. Knigge, M.P. Lance, L.J. Burgart, S.R. Hamilton, J.E. Allison,M.J. Lawson,M.E.Devens, J.J. Harrington, S.L. Hillman, Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Ann. Intern. Med. 149, 441-50 (2008). W81
17. T.F. Imperiale, D.F. Ransohoff, S.H. Itzkowitz, B.A. Turnbull, M.E. Ross, Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N. Engl. J. Med. 351, 2704-2714 (2004) (Pubitemid 39665324)
18. S. Itzkowitz, R. Brand, L. Jandorf, K. Durkee, J. Millholland, L. Rabeneck, P.C. Schroy, III, S. Sontag, D. Johnson, S. Markowitz, L. Paszat, and B.M. Berger, A Simplified, Noninvasive Stool DNA Test for Colorectal Cancer Detection. Am. J. Gastroenterol. 103, 2862-2870 (2008)
19. D.M. Hellebrekers, M.H. Lentjes, S.M. van den Bosch, V. Melotte, K.A.Wouters, K.L. Daenen, K.M. Smits, Y. Akiyama, Y. Yuasa, S. Sanduleanu, C.A. Khalid-de Bakker, D. Jonkers, M.P. Weijenberg, J. Louwagie, C.W. Van, B. Carvalho, G.A. Meijer, S.B. Baylin, J.G. Herman, A.P. de Bruine, E.M. Van, GATA4 and GATA5 arepotential tumor suppressors and biomarkers in colorectal cancer. Clin. Cancer Res. 15, 3990-3997 (2009)
20. M.S. Kim, J. Louwagie, B. Carvalho, J.S. Terhaar Sive Droste, H.L. Park, Y.K. Chae, K. Yamashita, J. Liu, K.L. Ostrow, S. Ling, R. Guerrero-Preston, S. Demokan, Z. Yalniz, N. Dalay, G.A. Meijer, C.W. Van, D. Sidransky, Promoter DNA methylation of oncostatin m receptor-beta as a novel diagnostic and therapeutic marker in colon cancer. PLoS One 4, e6555 (2009)
21. M. Li, W.D. Chen, N. Papadopoulos, S.N. Goodman, N.C. Bjerregaard, S. Laurberg, B. Levin, H. Juhl, N. Arber, H. Moinova, K. Durkee, K. Schmidt, Y. He, F. Diehl, V.E. Velculescu, S. Zhou, L.A. Diaz Jr., K.W. Kinzler, S.D. Markowitz, B. Vogelstein, Sensitive digital quantification of DNA methylation in clinical samples. Nat. Biotechnol. 27, 858-863 (2009)
22. B.M. Berger, D.A. Ahlquist, Stool DNA screening for colorectal neoplasia: biological and technical basis for high detection rates. Pathology 44, 80-88 (2012)
23. F. Diehl, K. Schmidt, K.H. Durkee, K.J. Moore, S.N. Goodman, A.P. Shuber, K.W. Kinzler, and B. Vogelstein, Analysis ofMutations in DNA Isolated From Plasma and Stool of Colorectal Cancer Patients. Gastroenterology 135, 489-498 (2008)
24. D. Whitney, J. Skoletsky, K. Moore, K. Boynton, L. Kann, R. Brand, S. Syngal, M. Lawson, A. Shuber, Enhanced retrieval of DNA from human fecal samples results in improved performance of colorectal cancer screening test. J. Mol. Diagn. 6, 386-395 (2004) (Pubitemid 39517408)
25. H. Zou, H. Allawi, X. Cao, M. Domanico, J. Harrington, W.R. Taylor, T. Yab, D.A. Ahlquist, G. Lidgard, Quantification of methylated markers with a multiplex methylation-specific technology. Clin. Chem. 58, 375-383 (2012)
26. C. Ostwald, M. Linnebacher, V. Weirich, F. Prall, Chromosomally and microsatellite stable colorectal carcinomas without the CpG island methylator phenotype in a molecular classification. Int. J. Oncol. 35, 321-327 (2009)
27. D.A. Ahlquist, J.E. Skoletsky, K.A. Boynton, J.J. Harrington, D.W. Mahoney, W.E. Pierceall, S.N. Thibodeau, A.P. Shuber, Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. Gastroenterology 119, 1219-1227 (2000)